-
New marker for early diagnosis of Alzheimer’s disease
An international, multicenter study led by Professor Jintai Yu, a researcher at the Tianqiao and Chrissy Chen Institute and a professor of neurology at Fudan University-affiliated Huashan Hospital, has found that increased volume of the sublateral ventricles is a genetic imaging marker of Alzheimer’s disease, and can be used to predict the risk of Alzheimer’s […]
-
Viviana Gradinaru Named Director of the Merkin Institute
Viviana Gradinaru, Lois and Victor Troendle Professor of Neuroscience and Biological Engineering and director of the Center for Molecular and Cellular Neuroscience at the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech, has been named the new director and Allen V. C. Davis and Lenabelle Davis Leadership Chair of the Richard N. Merkin Institute […]
-
Frontier Lab Director, Gerwin Schalk, speaks at Hybrid Mind Conference
Gerwin Schalk, PhD, the Director of the Chen Frontier Lab for Applied Neurotechnology, spoke today at the 1st International Conference on “The Hybrid Mind: Ethics and Regulation of Intelligent Neuroprostheses” hosted by the Clinical Neurotechnology Laboratory at Charité – Universitätsmedizin Berlin. Intelligent neuroprostheses are a type of medical device that are implanted or attached to […]
-
New neurosurgical technique: deep brain tumor resection with 3D exoscopy
A team led by Mao Ying, president of Fudan University-affiliated Huashan Hospital and director of the TCCI Translational Center, and Professor Zhu Wei from the Neurosurgery Department of Fudan University-affiliated Huashan Hospital, reported 25 cases of pineal region tumor resection with 3D exoscopy via infratentorial approach, which achieved satisfactory clinical outcomes. Neurosurgery has always been […]
-
2023 TCCI Fall Newsletter
As we shift into Autumn, we’re excited to tell you about two free meetings we’ve organized in November. We’ve scheduled them to be extremely convenient for those who are attending the Society for Neuroscience’s annual meeting in Washington DC in November of this year.
-
Stanford Researchers Develop Molecularly Imprinted Polymers for Continual, Real-time Sensing of Dopamine for Health Monitoring
In a recent paper published in ACS Nano, a team of researchers led by Professor Nicholas Melosh and Dr. Nofar Mintz Hemed in the Department of Materials Science and Engineering at Stanford University describe their innovative, dopamine-binding molecularly imprinted polymers (MIP) that have a limit of detection in the sub-nanomolar range and does not require […]
-
Unique evolutionary pathways during recurrence of different gliomas
Glioma recurrence has long plagued patients and neurosurgeons however with the development of molecular diagnosis of glioma, research recently published in the journal Nature, has become increasingly precise. A recent study by Mao Ying, President of Fudan University-affiliated Huashan Hospital and Director of TCCI Translational Center, and Professor Hua Wei from the Neurosurgery Department of […]
-
Drug Delivery Platform Uses Sound for Targeting
Chemotherapy as a treatment for cancer is one of the major medical success stories of the 20th century, but it’s far from perfect. Anyone who has been through chemotherapy or who has had a friend or loved one go through it will be familiar with its many side effects: hair loss, nausea, weakened immune system, […]
-
“Invisible” Cell Types and Gene Expression Revealed with Sequencing Data Analysis Improvement
In 2018, researchers in the Caltech laboratory of Yuki Oka, Chen Scholar, professor of biology and Heritage Medical Research Institute Investigator, made a major discovery: they identified a type of neuron, or brain cell, that mediates thirst satiation. But they were running into a problem: a state-of-the-art technique called single-cell RNA sequencing (scRNA-seq) could not […]
